Umut Aypar

8PUBLICATIONS
35CO-AUTHORS
Cancer diagnosisHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
Clinical Utility of Copy Number Abnormality Analysis in the Evaluation of Melanocytic Lesions for Diagnosis and Prognosis: An Evidence-Based Review from the Cancer Genomics Consortium Working Group for Melanocytic Lesions.

Cynthia Reyes Barron, Katherine B Geiersbach, Ahmed K Alomari

|Apr 30, 2024
Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.

Umut Aypar, Deepika Dilip, Ramya Gadde

|Apr 20, 2023
TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy.

William T Johnson, Nivetha Ganesan, Zachary D Epstein-Peterson

|Jul 09, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome.

Ozge Ceyhan-Birsoy, Pier Selenica, M Herman Chui

|Dec 04, 2020
A Performance Comparison of Commonly Used Assays to Detect RET Fusions.

Soo-Ryum Yang, Umut Aypar, Ezra Y Rosen

|Oct 20, 2020
Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.

Umut Aypar, Jinjuan Yao, Dory M Londono

Pageof 2

Frequent Collaborators

1 joint publications

Soo-Ryum Yang

1 joint publications

Ryma Benayed

1 joint publications

Alexander Drilon

1 joint publications

Natasha Rekhtman